medigraphic.com
ISSN 1870-2821 (Print)
Organo Oficial de la Asociación Mexicana de Mastología

2020, Number 1

<< Back Next >>

Rev Mex Mastol 2020; 10 (1)

Breast cancer and pregnancy by artificial insemination in mother with maternal age at risk

Portillo CKE, Aguilar TCR, Salcido RÓ

Language: Spanish
References: 16
Page: 18-24
PDF size: 216.71 Kb.


ABSTRACT

It is a 42-year-old female patient, mother terminated by breast cancer; patient gesta 1, pregnancy by artificial insemination; date of last menstruation May 9, 2018. Starts at 9 weeks of gestation, detecting the mass as the painful mother on palpation, a Physical examination is on the left, on the bottom, external, on the radio 4 of the watch, approximately 5 cm of mobile petrous consistency, irregular and painful on palpation; has a sonography report that reports a large vascularized tumor area, thick vessels and very suspicious lesion of malignant process; BIRADS 4B classification; biopsy with cutting needle and axilla by fine needle aspiration that reports moderately differentiated invasive ductal carcinoma with metastasis to axillary lymph nodes. Left modified radical mastectomy with axillary drainage is performed at 17 weeks of gestation and is subsequently managed with 8 cycles of adjuvant chemotherapy, as well as 25 cycles of radiotherapy and trastuzumab.


REFERENCES

  1. Dudenko D, Hidalgo JJ, Franco A, Lluch A, Cano A. Preservación de la fertilidad de emergencia en paciente con diagnóstico de cáncer de mama durante embarazo: caso clínico. Rev Iberoam Fert Rep Hum. 2019; 36. 27-31.

  2. Masson Doyma México S.A. Consenso Mexicano sobre diagnóstico y tratamiento del cáncer mamario. 2017.

  3. Ruiz R, Herrero C, Strasser-Weippl K, Touya D, St Louis J, Bukowski A et al. Epidemiology and pathophysiology of pregnancy-associated breast cancer: a review. Breast. 2017; 35: 136-141. doi: 10.1016/j.breast.2017.07.008. Epub 2017 Jul 18.

  4. Ara C, Giménez MJ, Cusidó M, Fabregas R, Sociedad Española de Senología y Patología Mamaria, con la colaboración de: Sección de Medicina Perinatal de la SEGO, Sociedad Española de Fertilidad, Sociedad Española de Contracepción. Consenso cáncer de mama y fertilidad. Revista de Senología y Patología Mamaria. 2015; 28 (4): 145-196.

  5. Christian N, Gemignani ML. Issues with fertility in young women with breast cancer. Curr Oncol Rep. 2019; 21: 58.

  6. Amant F, von Minckwitz G, Han SN, Bontenbal M, Ring AE, Giermek J et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013; 31 (20): 2532-2539.

  7. Froehlich K, Schmidt A, Heger JI, Al-Kawlani B, Aberl CA, Jeschke U et al. Breast cancer during pregnancy: maternal and fetal outcomes. Eur J Cancer. 2019; 115: 68-78.

  8. Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA et al. Reproductive history and mortality after breast cancer diagnosis. Obstet Gynecol. 2004; 104 (1): 146-154.

  9. Martínez MT, Bermejo B, Hernando C, Gambardella V, Cejalvo JM, Lluch A. Breast cancer in pregnant patients: a review of the literature. Eur J Obstet Gynecol Reprod Biol. 2018; 230: 222-227.

  10. Committee Opinion No. 723: Guidelines for diagnostic imaging during pregnancy and lactation. Committee on obstetric practice. Obstet Gynecol. 2017; 130 (4): e210-e216. doi: 10.1097/AOG.0000000000002355.

  11. ACR-SPR Practice Parameter for imaging pregnant or potentially pregnant adolescents and women with ionizing radiation. Revised 2018 (Resolution 39). [Consulted 5 December 2018]: https://www.acr. org/-/media/ACR/Files/Practice-Parameters/Pregnant-Pts.pdf.

  12. Peccatori FA, Codacci-Pisanelli G, Del Grande M, Scarfone G, Zugni F, Petralia G. Whole body MRI for systemic staging of breast cancer in pregnant women. Breast. 2017; 35: 177-181. doi: 10.1016/j. breast.2017.07.014.

  13. Lambertini M, Peccatori FA, Azim HA Jr. Targeted agents for cancer treatment during pregnancy. Cancer Treat Rev. 2015; 41 (4): 301-309. doi: 10.1016/j.ctrv.2015.03.001.

  14. Zagouri F, Sergentanis TN, Chrysikos D, Papadimitriou CA, Dimopoulos MA, Bartsch R. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013; 137 (2): 349-357. doi: 10.1007/s10549-012-2368-y.

  15. Sekar R, Stone PR. Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol. 2007; 110: 507-510.

  16. Yu HH, Cheung PS, Leung RC, Leung TN, Kwan WH. Current management of pregnancy-associated breast cancer. Hong Kong Med J. 2017; 23 (4): 387-394. doi: 10.12809/hkmj166049.




2020     |     www.medigraphic.com